Global Human Rabies Vaccine Market Growth 2022-2028
As the global economy mends, the 2021 growth of Human Rabies Vaccine will have significant change from previous year. According to our latest study, the global Human Rabies Vaccine market size is USD million in 2022 from USD 1033 million in 2021, with a change of % between 2021 and 2022. The global Human Rabies Vaccine market size will reach USD 1402.1 million in 2028, growing at a CAGR of 4.5% over the analysis period.
The United States Human Rabies Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Rabies Vaccine market, reaching US$ million by the year 2028. As for the Europe Human Rabies Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Human Rabies Vaccine players cover Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, and Chengda Bio, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Rabies Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Pre-Exposure Vaccine
Post-Exposure Vaccine
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Rabies Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Human Rabies Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Human Rabies Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Human Rabies Vaccine Segment by Type
2.2.1 Vero Cell
2.2.2 BHK
2.2.3 Chick Embryo Cell
2.2.4 Human Diploid Cells
2.2.5 Others
2.3 Human Rabies Vaccine Sales by Type
2.3.1 Global Human Rabies Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Human Rabies Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Human Rabies Vaccine Sale Price by Type (2017-2022)
2.4 Human Rabies Vaccine Segment by Application
2.4.1 Pre-Exposure Vaccine
2.4.2 Post-Exposure Vaccine
2.5 Human Rabies Vaccine Sales by Application
2.5.1 Global Human Rabies Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Human Rabies Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Human Rabies Vaccine Sale Price by Application (2017-2022)
3 Global Human Rabies Vaccine by Company
3.1 Global Human Rabies Vaccine Breakdown Data by Company
3.1.1 Global Human Rabies Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Human Rabies Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Human Rabies Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Human Rabies Vaccine Revenue by Company (2020-2022)
3.2.2 Global Human Rabies Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Human Rabies Vaccine Sale Price by Company
3.4 Key Manufacturers Human Rabies Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Rabies Vaccine Product Location Distribution
3.4.2 Players Human Rabies Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Rabies Vaccine by Geographic Region
4.1 World Historic Human Rabies Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Human Rabies Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Human Rabies Vaccine Annual Revenue by Geographic Region
4.2 World Historic Human Rabies Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Human Rabies Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Human Rabies Vaccine Annual Revenue by Country/Region
4.3 Americas Human Rabies Vaccine Sales Growth
4.4 APAC Human Rabies Vaccine Sales Growth
4.5 Europe Human Rabies Vaccine Sales Growth
4.6 Middle East & Africa Human Rabies Vaccine Sales Growth
5 Americas
5.1 Americas Human Rabies Vaccine Sales by Country
5.1.1 Americas Human Rabies Vaccine Sales by Country (2017-2022)
5.1.2 Americas Human Rabies Vaccine Revenue by Country (2017-2022)
5.2 Americas Human Rabies Vaccine Sales by Type
5.3 Americas Human Rabies Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Rabies Vaccine Sales by Region
6.1.1 APAC Human Rabies Vaccine Sales by Region (2017-2022)
6.1.2 APAC Human Rabies Vaccine Revenue by Region (2017-2022)
6.2 APAC Human Rabies Vaccine Sales by Type
6.3 APAC Human Rabies Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Rabies Vaccine by Country
7.1.1 Europe Human Rabies Vaccine Sales by Country (2017-2022)
7.1.2 Europe Human Rabies Vaccine Revenue by Country (2017-2022)
7.2 Europe Human Rabies Vaccine Sales by Type
7.3 Europe Human Rabies Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Rabies Vaccine by Country
8.1.1 Middle East & Africa Human Rabies Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Human Rabies Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Human Rabies Vaccine Sales by Type
8.3 Middle East & Africa Human Rabies Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Rabies Vaccine
10.3 Manufacturing Process Analysis of Human Rabies Vaccine
10.4 Industry Chain Structure of Human Rabies Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Rabies Vaccine Distributors
11.3 Human Rabies Vaccine Customer
12 World Forecast Review for Human Rabies Vaccine by Geographic Region
12.1 Global Human Rabies Vaccine Market Size Forecast by Region
12.1.1 Global Human Rabies Vaccine Forecast by Region (2023-2028)
12.1.2 Global Human Rabies Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Rabies Vaccine Forecast by Type
12.7 Global Human Rabies Vaccine Forecast by Application
13 Key Players Analysis
13.1 Bharat Biotech
13.1.1 Bharat Biotech Company Information
13.1.2 Bharat Biotech Human Rabies Vaccine Product Offered
13.1.3 Bharat Biotech Human Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bharat Biotech Main Business Overview
13.1.5 Bharat Biotech Latest Developments
13.2 Bavarian Nordic
13.2.1 Bavarian Nordic Company Information
13.2.2 Bavarian Nordic Human Rabies Vaccine Product Offered
13.2.3 Bavarian Nordic Human Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bavarian Nordic Main Business Overview
13.2.5 Bavarian Nordic Latest Developments
13.3 Sanofi-Pasteur
13.3.1 Sanofi-Pasteur Company Information
13.3.2 Sanofi-Pasteur Human Rabies Vaccine Product Offered
13.3.3 Sanofi-Pasteur Human Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi-Pasteur Main Business Overview
13.3.5 Sanofi-Pasteur Latest Developments
13.4 Chengda Bio
13.4.1 Chengda Bio Company Information
13.4.2 Chengda Bio Human Rabies Vaccine Product Offered
13.4.3 Chengda Bio Human Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Chengda Bio Main Business Overview
13.4.5 Chengda Bio Latest Developments
13.5 KANGH
13.5.1 KANGH Company Information
13.5.2 KANGH Human Rabies Vaccine Product Offered
13.5.3 KANGH Human Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 KANGH Main Business Overview
13.5.5 KANGH Latest Developments
13.6 Prcmise
13.6.1 Prcmise Company Information
13.6.2 Prcmise Human Rabies Vaccine Product Offered
13.6.3 Prcmise Human Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Prcmise Main Business Overview
13.6.5 Prcmise Latest Developments
13.7 Henan Grand Biopharma
13.7.1 Henan Grand Biopharma Company Information
13.7.2 Henan Grand Biopharma Human Rabies Vaccine Product Offered
13.7.3 Henan Grand Biopharma Human Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Henan Grand Biopharma Main Business Overview
13.7.5 Henan Grand Biopharma Latest Developments
13.8 Zhuoyi Biological
13.8.1 Zhuoyi Biological Company Information
13.8.2 Zhuoyi Biological Human Rabies Vaccine Product Offered
13.8.3 Zhuoyi Biological Human Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Zhuoyi Biological Main Business Overview
13.8.5 Zhuoyi Biological Latest Developments
13.9 ZhongKe Biopharm
13.9.1 ZhongKe Biopharm Company Information
13.9.2 ZhongKe Biopharm Human Rabies Vaccine Product Offered
13.9.3 ZhongKe Biopharm Human Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 ZhongKe Biopharm Main Business Overview
13.9.5 ZhongKe Biopharm Latest Developments
13.10 Ningbo Rongan Biological
13.10.1 Ningbo Rongan Biological Company Information
13.10.2 Ningbo Rongan Biological Human Rabies Vaccine Product Offered
13.10.3 Ningbo Rongan Biological Human Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Ningbo Rongan Biological Main Business Overview
13.10.5 Ningbo Rongan Biological Latest Developments
13.11 Indian Immunologicals
13.11.1 Indian Immunologicals Company Information
13.11.2 Indian Immunologicals Human Rabies Vaccine Product Offered
13.11.3 Indian Immunologicals Human Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Indian Immunologicals Main Business Overview
13.11.5 Indian Immunologicals Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Human Rabies Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Human Rabies Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Vero Cell
Table 4. Major Players of BHK
Table 5. Major Players of Chick Embryo Cell
Table 6. Major Players of Human Diploid Cells
Table 7. Major Players of Others
Table 8. Global Human Rabies Vaccine Sales by Type (2017-2022) & (K Units)
Table 9. Global Human Rabies Vaccine Sales Market Share by Type (2017-2022)
Table 10. Global Human Rabies Vaccine Revenue by Type (2017-2022) & ($ million)
Table 11. Global Human Rabies Vaccine Revenue Market Share by Type (2017-2022)
Table 12. Global Human Rabies Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global Human Rabies Vaccine Sales by Application (2017-2022) & (K Units)
Table 14. Global Human Rabies Vaccine Sales Market Share by Application (2017-2022)
Table 15. Global Human Rabies Vaccine Revenue by Application (2017-2022)
Table 16. Global Human Rabies Vaccine Revenue Market Share by Application (2017-2022)
Table 17. Global Human Rabies Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global Human Rabies Vaccine Sales by Company (2020-2022) & (K Units)
Table 19. Global Human Rabies Vaccine Sales Market Share by Company (2020-2022)
Table 20. Global Human Rabies Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Human Rabies Vaccine Revenue Market Share by Company (2020-2022)
Table 22. Global Human Rabies Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers Human Rabies Vaccine Producing Area Distribution and Sales Area
Table 24. Players Human Rabies Vaccine Products Offered
Table 25. Human Rabies Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Human Rabies Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Human Rabies Vaccine Sales Market Share Geographic Region (2017-2022)
Table 30. Global Human Rabies Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Human Rabies Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Human Rabies Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Human Rabies Vaccine Sales Market Share by Country/Region (2017-2022)
Table 34. Global Human Rabies Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Human Rabies Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Human Rabies Vaccine Sales by Country (2017-2022) & (K Units)
Table 37. Americas Human Rabies Vaccine Sales Market Share by Country (2017-2022)
Table 38. Americas Human Rabies Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Human Rabies Vaccine Revenue Market Share by Country (2017-2022)
Table 40. Americas Human Rabies Vaccine Sales by Type (2017-2022) & (K Units)
Table 41. Americas Human Rabies Vaccine Sales Market Share by Type (2017-2022)
Table 42. Americas Human Rabies Vaccine Sales by Application (2017-2022) & (K Units)
Table 43. Americas Human Rabies Vaccine Sales Market Share by Application (2017-2022)
Table 44. APAC Human Rabies Vaccine Sales by Region (2017-2022) & (K Units)
Table 45. APAC Human Rabies Vaccine Sales Market Share by Region (2017-2022)
Table 46. APAC Human Rabies Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Human Rabies Vaccine Revenue Market Share by Region (2017-2022)
Table 48. APAC Human Rabies Vaccine Sales by Type (2017-2022) & (K Units)
Table 49. APAC Human Rabies Vaccine Sales Market Share by Type (2017-2022)
Table 50. APAC Human Rabies Vaccine Sales by Application (2017-2022) & (K Units)
Table 51. APAC Human Rabies Vaccine Sales Market Share by Application (2017-2022)
Table 52. Europe Human Rabies Vaccine Sales by Country (2017-2022) & (K Units)
Table 53. Europe Human Rabies Vaccine Sales Market Share by Country (2017-2022)
Table 54. Europe Human Rabies Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Human Rabies Vaccine Revenue Market Share by Country (2017-2022)
Table 56. Europe Human Rabies Vaccine Sales by Type (2017-2022) & (K Units)
Table 57. Europe Human Rabies Vaccine Sales Market Share by Type (2017-2022)
Table 58. Europe Human Rabies Vaccine Sales by Application (2017-2022) & (K Units)
Table 59. Europe Human Rabies Vaccine Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Human Rabies Vaccine Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Human Rabies Vaccine Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Human Rabies Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Human Rabies Vaccine Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Human Rabies Vaccine Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Human Rabies Vaccine Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Human Rabies Vaccine Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Human Rabies Vaccine Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Human Rabies Vaccine
Table 69. Key Market Challenges & Risks of Human Rabies Vaccine
Table 70. Key Industry Trends of Human Rabies Vaccine
Table 71. Human Rabies Vaccine Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Human Rabies Vaccine Distributors List
Table 74. Human Rabies Vaccine Customer List
Table 75. Global Human Rabies Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Human Rabies Vaccine Sales Market Forecast by Region
Table 77. Global Human Rabies Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Human Rabies Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Human Rabies Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Human Rabies Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Human Rabies Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Human Rabies Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Human Rabies Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Human Rabies Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Human Rabies Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Human Rabies Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Human Rabies Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Human Rabies Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Human Rabies Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Human Rabies Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Human Rabies Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Human Rabies Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Human Rabies Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Human Rabies Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 95. Bharat Biotech Basic Information, Human Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. Bharat Biotech Human Rabies Vaccine Product Offered
Table 97. Bharat Biotech Human Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. Bharat Biotech Main Business
Table 99. Bharat Biotech Latest Developments
Table 100. Bavarian Nordic Basic Information, Human Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Bavarian Nordic Human Rabies Vaccine Product Offered
Table 102. Bavarian Nordic Human Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. Bavarian Nordic Main Business
Table 104. Bavarian Nordic Latest Developments
Table 105. Sanofi-Pasteur Basic Information, Human Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. Sanofi-Pasteur Human Rabies Vaccine Product Offered
Table 107. Sanofi-Pasteur Human Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Sanofi-Pasteur Main Business
Table 109. Sanofi-Pasteur Latest Developments
Table 110. Chengda Bio Basic Information, Human Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. Chengda Bio Human Rabies Vaccine Product Offered
Table 112. Chengda Bio Human Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. Chengda Bio Main Business
Table 114. Chengda Bio Latest Developments
Table 115. KANGH Basic Information, Human Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. KANGH Human Rabies Vaccine Product Offered
Table 117. KANGH Human Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. KANGH Main Business
Table 119. KANGH Latest Developments
Table 120. Prcmise Basic Information, Human Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 121. Prcmise Human Rabies Vaccine Product Offered
Table 122. Prcmise Human Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. Prcmise Main Business
Table 124. Prcmise Latest Developments
Table 125. Henan Grand Biopharma Basic Information, Human Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 126. Henan Grand Biopharma Human Rabies Vaccine Product Offered
Table 127. Henan Grand Biopharma Human Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. Henan Grand Biopharma Main Business
Table 129. Henan Grand Biopharma Latest Developments
Table 130. Zhuoyi Biological Basic Information, Human Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 131. Zhuoyi Biological Human Rabies Vaccine Product Offered
Table 132. Zhuoyi Biological Human Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. Zhuoyi Biological Main Business
Table 134. Zhuoyi Biological Latest Developments
Table 135. ZhongKe Biopharm Basic Information, Human Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 136. ZhongKe Biopharm Human Rabies Vaccine Product Offered
Table 137. ZhongKe Biopharm Human Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 138. ZhongKe Biopharm Main Business
Table 139. ZhongKe Biopharm Latest Developments
Table 140. Ningbo Rongan Biological Basic Information, Human Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 141. Ningbo Rongan Biological Human Rabies Vaccine Product Offered
Table 142. Ningbo Rongan Biological Human Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 143. Ningbo Rongan Biological Main Business
Table 144. Ningbo Rongan Biological Latest Developments
Table 145. Indian Immunologicals Basic Information, Human Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 146. Indian Immunologicals Human Rabies Vaccine Product Offered
Table 147. Indian Immunologicals Human Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 148. Indian Immunologicals Main Business
Table 149. Indian Immunologicals Latest Developments
List of Figures
Figure 1. Picture of Human Rabies Vaccine
Figure 2. Human Rabies Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Rabies Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Human Rabies Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Human Rabies Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Vero Cell
Figure 10. Product Picture of BHK
Figure 11. Product Picture of Chick Embryo Cell
Figure 12. Product Picture of Human Diploid Cells
Figure 13. Product Picture of Others
Figure 14. Global Human Rabies Vaccine Sales Market Share by Type in 2021
Figure 15. Global Human Rabies Vaccine Revenue Market Share by Type (2017-2022)
Figure 16. Human Rabies Vaccine Consumed in Pre-Exposure Vaccine
Figure 17. Global Human Rabies Vaccine Market: Pre-Exposure Vaccine (2017-2022) & (K Units)
Figure 18. Human Rabies Vaccine Consumed in Post-Exposure Vaccine
Figure 19. Global Human Rabies Vaccine Market: Post-Exposure Vaccine (2017-2022) & (K Units)
Figure 20. Global Human Rabies Vaccine Sales Market Share by Application (2017-2022)
Figure 21. Global Human Rabies Vaccine Revenue Market Share by Application in 2021
Figure 22. Human Rabies Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Human Rabies Vaccine Revenue Market Share by Company in 2021
Figure 24. Global Human Rabies Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Human Rabies Vaccine Revenue Market Share by Geographic Region in 2021
Figure 26. Global Human Rabies Vaccine Sales Market Share by Region (2017-2022)
Figure 27. Global Human Rabies Vaccine Revenue Market Share by Country/Region in 2021
Figure 28. Americas Human Rabies Vaccine Sales 2017-2022 (K Units)
Figure 29. Americas Human Rabies Vaccine Revenue 2017-2022 ($ Millions)
Figure 30. APAC Human Rabies Vaccine Sales 2017-2022 (K Units)
Figure 31. APAC Human Rabies Vaccine Revenue 2017-2022 ($ Millions)
Figure 32. Europe Human Rabies Vaccine Sales 2017-2022 (K Units)
Figure 33. Europe Human Rabies Vaccine Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Human Rabies Vaccine Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Human Rabies Vaccine Revenue 2017-2022 ($ Millions)
Figure 36. Americas Human Rabies Vaccine Sales Market Share by Country in 2021
Figure 37. Americas Human Rabies Vaccine Revenue Market Share by Country in 2021
Figure 38. United States Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Human Rabies Vaccine Sales Market Share by Region in 2021
Figure 43. APAC Human Rabies Vaccine Revenue Market Share by Regions in 2021
Figure 44. China Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Human Rabies Vaccine Sales Market Share by Country in 2021
Figure 51. Europe Human Rabies Vaccine Revenue Market Share by Country in 2021
Figure 52. Germany Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Human Rabies Vaccine Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Human Rabies Vaccine Revenue Market Share by Country in 2021
Figure 59. Egypt Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Human Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Human Rabies Vaccine in 2021
Figure 65. Manufacturing Process Analysis of Human Rabies Vaccine
Figure 66. Industry Chain Structure of Human Rabies Vaccine
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
